EQRx to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 23, 2022
EQRx, a pharmaceutical company focused on providing innovative medicines at lower prices, announced a conference call on March 23, 2022, at 8:00 a.m. ET. The call will cover the financial results for Q4 and the full year 2021, along with a business update. Interested parties can join via a live webcast or by calling the provided numbers. EQRx, launched in January 2020, aims to efficiently develop medicines with strategic partnerships in the healthcare system, targeting high-cost drug categories.
- EQRx is committed to lowering drug prices while providing innovative medicines.
- The company has emerging partnerships with leading payers and providers.
- No detailed financial metrics or projections were provided ahead of the conference call.
Insights
Analyzing...
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced it will host a conference call and webcast on Wednesday, March 23, 2022, at 8:00 a.m. ET to report its fourth quarter and full year 2021 financial results and provide a business update.
A live webcast can be accessed by visiting the Investors section of the Company’s website at investors.eqrx.com. The conference call can be accessed by dialing 855-718-8094 (domestic) or 484-747-6788 (international) and referring to conference ID 4596972. The webcast will be made available for replay on the Company's website beginning approximately two hours after the event.
About EQRx
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is purpose-built, at scale, with a growing catalog of medicines in development in high-cost drug categories and emerging partnerships with leading payers and providers. Leveraging cutting-edge science and technology and strategic partnerships with stakeholders from across the healthcare system, EQRx aims to provide innovative, patent-protected medicines more efficiently and cost-effectively than ever before. To learn more, visit www.eqrx.com and follow us on social media: Twitter: @EQRxInc, LinkedIn, Instagram: @eqrxinc.
EQRx™ and Remaking Medicine™ are trademarks of EQRx.
EQRx Contacts:
Media:
Dan Budwick
1AB
dan@1abmedia.com
Investors:
investors@eqrx.com
FAQ
When will EQRx report its Q4 and full year 2021 financial results?
How can I access the EQRx conference call?
What is the purpose of the EQRx conference call?
Where can I find the webcast of the EQRx conference call?
